Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Clinical trial NCT01520389 · COMPLETED

Trial details

NCT number: NCT01520389
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Colorectal Cancer Squamous Cell Head and Neck Cancer Non Small Cell Lung Cancer Triple Negative Breast Cancer

Start date: 2012-01-01
Primary completion: 2015-12-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.